Technology
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its ‘VLP Peanut’ vaccine candidate in peanut-allergic patients on Monday.
Eqtec wins bid for renewable gas plant in France
Eqtec announced on Monday that, alongside infrastructure owner Idex, it has been awarded a project to develop a plant in Nouvelle-Aquitaine, France.
Clean Power Hydrogen's New Zealand partner receives order
UK-based green hydrogen technology and manufacturing specialist Clean Power Hydrogen (CPH2) announced on Monday that its New Zealand-based manufacturing partner Fabrum Solutions has received an order from Japanese construction company Obayashi Corporation for a 1MW ‘MFE220’ unit.
Avacta to present tumour medicine data at cancer research meeting
Life science company Avacta Group announced on Monday that it will present a poster on its novel ‘preCISION’ medicine, ‘AVA3996’, at the American Association for Cancer Research (AACR) 2023 annual meeting in Florida on 16 April.
Hyve Group confident after positive first half
Events business Hyve Group said in an update on Monday that it was expecting to generate revenue for the first half of between £95m and £100m.
Northamber confident despite swinging to first-half EBITDA loss
Specialist audio-visual and IT distributor Northamber reported first-half revenue growth of 4. 1% year-on-year on Monday, to £33. 6m, although it did swing to an EBITDA loss amid inflationary pressures.
Spectral MD completes enrolment for AI training study
Predictive analytics specialist Spectral MD announced completion of enrolment for its United States-based burn artificial intelligence (AI) training study on Monday, supported by the Biomedical Advanced Research and Development Authority (BARDA).